These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35743640)

  • 1. Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA).
    Park JK; Kim D; Lee JM; Lee KH; Lee KT; Park JK; Lee JK
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
    J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of primary sclerosing cholangitis with increased IgG4 levels.
    Manganis CD; Chapman RW; Culver EL
    World J Gastroenterol; 2020 Jun; 26(23):3126-3144. PubMed ID: 32684731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
    Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
    Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
    Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center.
    Swensson J; Tirkes T; Tann M; Cui E; Sandrasegaran K
    Abdom Radiol (NY); 2019 Jun; 44(6):2111-2115. PubMed ID: 30783729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Primary Sclerosing Cholangitis from Similar Diseases of Autoimmune Origin.
    Kunovsky L; Dite P; Hornakova L; Dolina J; Uvirova M; Kojecky V; Martinek A; Jabandziev P
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):398-403. PubMed ID: 34551027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
    Tanaka A
    Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
    Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.
    Nakazawa T; Naitoh I; Hayashi K; Okumura F; Miyabe K; Yoshida M; Yamashita H; Ohara H; Joh T
    J Gastroenterol; 2012 Jan; 47(1):79-87. PubMed ID: 21947649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
    Koyabu M; Uchida K; Miyoshi H; Sakaguchi Y; Fukui T; Ikeda H; Takaoka M; Hirohara J; Nishio A; Uemura Y; Uemoto S; Okazaki K
    J Gastroenterol; 2010 Jul; 45(7):732-41. PubMed ID: 20087609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
    Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
    Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis.
    Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Ohara H; Joh T
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1104-9. PubMed ID: 25594435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
    Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of IgG4-related sclerosing cholangitis.
    Nakazawa T; Naitoh I; Hayashi K; Miyabe K; Simizu S; Joh T
    World J Gastroenterol; 2013 Nov; 19(43):7661-70. PubMed ID: 24282356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
    Boonstra K; Culver EL; de Buy Wenniger LM; van Heerde MJ; van Erpecum KJ; Poen AC; van Nieuwkerk KM; Spanier BW; Witteman BJ; Tuynman HA; van Geloven N; van Buuren H; Chapman RW; Barnes E; Beuers U; Ponsioen CY
    Hepatology; 2014 May; 59(5):1954-63. PubMed ID: 24375491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geoepidemiology of primary sclerosing cholangitis: a critical review.
    Tanaka A; Takikawa H
    J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma.
    Yata M; Suzuki K; Furuhashi N; Kawakami K; Kawai Y; Naganawa S
    Clin Radiol; 2016 Mar; 71(3):203-10. PubMed ID: 26703117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.